117
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Different Roles of TP53 Codon 72 Polymorphism in Type 2 Diabetes and Its Complications: Evidence from a Case-Control Study on a Chinese Han Population

, , , , & ORCID Icon
Pages 4259-4268 | Published online: 07 Aug 2021

References

  • Schmidt AM. Highlighting diabetes mellitus: the epidemic continues. Arterioscler Thromb Vasc Biol. 2018;38(1):e1–e8. doi:10.1161/ATVBAHA.117.310221
  • Taylor R. Type 2 diabetes: etiology and reversibility. Diabetes Care. 2013;36(4):1047–1055. doi:10.2337/dc12-1805
  • Javeed N, Matveyenko AV. Circadian etiology of type 2 diabetes mellitus. Physiology (Bethesda). 2018;33(2):138–150. doi:10.1152/physiol.00003.2018
  • Alharbi KK, Abudawood M, Ali khan I. Amino-acid amendment of Arginine-325-Tryptophan in rs13266634 genetic polymorphism studies of the SLC30A8 gene with type 2 diabetes-mellitus patients featuring a positive family history in the Saudi population. J King Saud Univ Sci. 2021;33(1):101258. doi:10.1016/j.jksus.2020.101258
  • Ortega FJ, Moreno-Navarrete JM, Mayas D, et al. Inflammation and insulin resistance exert dual effects on adipose tissue tumor protein 53 expression. Int J Obes (Lond). 2014;38(5):737–745. doi:10.1038/ijo.2013.163
  • Kung CP, Murphy ME. The role of the p53 tumor suppressor in metabolism and diabetes. J Endocrinol. 2016;231(2):R61–R75. doi:10.1530/JOE-16-0324
  • Kodal JB, Vedel-Krogh S, Kobylecki CJ, Nordestgaard BG, Bojesen SE. TP53 Arg72Pro, mortality after cancer, and all-cause mortality in 105,200 individuals. Sci Rep. 2017;7(1):336. doi:10.1038/s41598-017-00427-x
  • Dumont P, Leu JI, Della Pietra AC 3rd, George DL, Murphy M. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet. 2003;33(3):357–365. doi:10.1038/ng1093
  • Kung CP, Leu JI, Basu S, et al. The P72R polymorphism of p53 predisposes to obesity and metabolic dysfunction. Cell Rep. 2016;14(10):2413–2425. doi:10.1016/j.celrep.2016.02.037
  • Reiling E, Speksnijder EN, Pronk AC, et al. Human TP53 polymorphism (rs1042522) modelled in mouse does not affect glucose metabolism and body composition. Sci Rep. 2014;4:4091. doi:10.1038/srep04091
  • Molchadsky A, Ezra O, Amendola PG, et al. p53 is required for brown adipogenic differentiation and has a protective role against diet-induced obesity. Cell Death Differ. 2013;20(5):774–783. doi:10.1038/cdd.2013.9
  • Park JH, Zhuang J, Li J, Hwang PM. p53 as guardian of the mitochondrial genome. FEBS Lett. 2016;590(7):924–934. doi:10.1002/1873-3468.12061
  • American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S13–S28. doi:10.2337/dc19-S002
  • Lacroix M, Riscal R, Arena G, Linares LK, Le Cam L. Metabolic functions of the tumor suppressor p53: implications in normal physiology, metabolic disorders, and cancer. Mol Metab. 2020;33:2–22. doi:10.1016/j.molmet.2019.10.002
  • Kang JG, Lago CU, Lee JE, et al. A mouse Homolog of a Human TP53 Germline mutation reveals a lipolytic activity of p53. Cell Rep. 2020;30(3):783–792.e785. doi:10.1016/j.celrep.2019.12.074
  • Krstic J, Reinisch I, Schupp M, Schulz TJ, Prokesch A. p53 functions in adipose tissue metabolism and homeostasis. Int J Mol Sci. 2018;19(9):2622. doi:10.3390/ijms19092622
  • Joruiz SM, Beck JA, Horikawa I, Harris CC. The Δ133p53 Isoforms, Tuners of the p53 Pathway. Cancers (Basel). 2020;12(11):3422. doi:10.3390/cancers12113422
  • Kazak L, Reyes A, Holt IJ. Minimizing the damage: repair pathways keep mitochondrial DNA intact. Nat Rev Mol Cell Biol. 2012;13(10):659–671. doi:10.1038/nrm3439
  • Gaulton KJ, Willer CJ, Li Y, et al. Comprehensive association study of type 2 diabetes and related quantitative traits with 222 candidate genes. Diabetes. 2008;57(11):3136–3144. doi:10.2337/db07-1731
  • Burgdorf KS, Grarup N, Justesen JM, et al. Studies of the association of Arg72Pro of tumor suppressor protein p53 with type 2 diabetes in a combined analysis of 55,521 Europeans. PLoS One. 2011;6(1):e15813. doi:10.1371/journal.pone.0015813
  • Sliwinska A, Kasznicki J, Kosmalski M, et al. Tumour protein 53 is linked with type 2 diabetes mellitus. Indian J Med Res. 2017;146(2):237–243. doi:10.4103/ijmr.IJMR_1401_15
  • Kaludercic N, Di Lisa F. Mitochondrial ROS formation in the pathogenesis of diabetic cardiomyopathy. Front Cardiovasc Med. 2020;7:12. doi:10.3389/fcvm.2020.00012
  • Tatsch E, De Carvalho JA, Hausen BS, et al. Oxidative DNA damage is associated with inflammatory response, insulin resistance and microvascular complications in type 2 diabetes. Mutat Res. 2015;782:17–22. doi:10.1016/j.mrfmmm.2015.10.003